Peter L. Salgo, MD: We have been teasing our viewers because we’ve been talking about novel therapies, something in the pipeline, something good…One of the new drugs is nusinersen. Peter L. Salgo, MD: ...

The patients, from 5 referral centers, were followed for at least 6 months and showed modest improvements in both motor and functional scales when treated with the antisense oligonucleotide for spinal ...

Discover comprehensive details about Nusinersen, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Nusinersen injection is injected intrathecally (into the backbone) over 1-3 minutes so that it reaches the cerebrospinal fluid (CSF), the fluid that bathes the brain and the spinal cord. Dosage & When ...

BOSTON -- Upper limb function and walking ability were largely preserved in adults with spinal muscular atrophy (SMA) treated with nusinersen (Spinraza), early results from an ongoing trial indicated.

Treatment with SPINRAZA improved or stabilized motor function across patient populations, including young adults The longer-term safety profile of SPINRAZA was consistent among a broad spectrum of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Monday - Friday, 6:00 - 7:00 PM ET Ionis Pharmaceutical shares jumped 30 percent on Monday on positive news of phase 3 data for its spinal muscular atrophy drug called Nusinersen, on which it ...

Next review: The guidance on this technology will be reviewed and published by the end of the managed access agreement in 5 years. There is a managed access agreement, which includes a commercial ...